Division of Surgical and Interventional Sciences, University College London, London, UK.
Division of Surgery, Urology Department, University College London Hospitals Trust, London, UK; National Medical Laser Centre, University College London, London, UK.
Since the first report of the use of photodynamic therapy (PDT) for prostate cancer in 1990 it has been investigated as a primary and a salvage treatment, using either whole gland or focal approaches. Since 1990 advances in the transperineal approach to the prostate, coupled with photosensitizers which have a short drug-light interval and minimal skin phototoxicity, have resulted in major advances in the field. This review will look at the work done to date, and the ongoing studies which help to define the place of PDT as a useful treatment modality for organ-confined prostate cancer.
Written by:
Moore CM, Emberton M, Bown SG. Are you the author?
Reference: Lasers Surg Med. 2011 Sep;43(7):768-75.
PubMed Abstract
PMID: 22057504
UroToday.com Prostate Cancer Section
